Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series

BACKGROUND: Data regarding the safety and effectiveness of aromatase inhibitors (AIs) as monotherapy or combined with gonadotropin-releasing hormone (GnRH) analogue in male breast cancer are scarce. METHODS: In this retrospective chart review, cases of male breast cancer patients treated with AIs wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zagouri, F, Sergentanis, T N, Koutoulidis, V, Sparber, C, Steger, G G, Dubsky, P, Zografos, G C, Psaltopoulou, T, Gnant, M, Dimopoulos, M-A, Bartsch, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681005/
https://www.ncbi.nlm.nih.gov/pubmed/23722469
http://dx.doi.org/10.1038/bjc.2013.255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681005/
https://www.ncbi.nlm.nih.gov/pubmed/23722469
http://dx.doi.org/10.1038/bjc.2013.255

Ejemplares similares